This may be a breakthrough for millions of Poles. The first specified migraine drug in the EU

Zdjęcie: Foto: AdobeStock


The European Commission has decided that Aquipta (atogepant) will be approved for the emergency treatment of migraine attacks in adults. Studies indicate that the preparation can effectively destruct pain within 2 hours of administration. The effect lasts up to 48 hours.